Articles tagged with Covid 19 Vaccines
Researchers found that brief scientific literacy interventions can undermine conspiracy beliefs, particularly those built on faulty reasoning. These interventions were most effective against novel conspiracies and among high-conspiracy groups.
Researchers at Helmholtz Munich identified a mechanism explaining Long COVID's neurological symptoms: SARS-CoV-2 spike protein remains in the brain for up to four years after infection. mRNA COVID-19 vaccines significantly reduce spike protein accumulation, but persistent presence poses a toxic risk.
The study found that irritability was the most common systemic reaction in children under 2 years, followed by fever and fatigue or sleepiness. Maternal vaccination is thought to be a factor in the higher prevalence of reactions after the first dose.
A recent study surveyed over 1,000 English-dominant, bilingual, and Spanish-dominant Latino users of Facebook and Instagram in the US. Latinos who use Spanish-language social media for news were found to be more susceptible to false political narratives, with a 11 percentage point increase in belief in these claims.
A Korean University College of Medicine study investigated COVID-19 vaccine safety in patients with atrial fibrillation/flutter. The research found no significant increase in the risk of thromboembolic events following COVID-19 vaccination, but patients without anticoagulant therapy were at higher risk. The study highlights the importa...
A unique COVID-19 and flu vaccine clinic at the UC Davis MIND Institute has shown remarkable success in increasing vaccination rates among individuals with neurodevelopmental disabilities. The clinic's innovative approach, which incorporates community partners and tailored care plans, has resulted in a 99.3% success rate over two years.
Researchers at Kumamoto University have developed a cutting-edge diagnostic tool, Intelli-OVI, to rapidly identify emerging SARS-CoV-2 variants. This system combines advanced DNA detection technology with computational algorithms to offer a quicker and more cost-effective method of monitoring viral mutations.
A randomized clinical trial found that simultaneous administration of mRNA COVID-19 and inactivated influenza vaccines had comparable reactogenicity to sequential administration. This suggests a safe option for co-administration of these vaccines.
A retrospective cohort study found associations between COVID-19 and the long-term risk of various autoimmune and autoinflammatory connective tissue disorders. Long-term monitoring and care are crucial to mitigate these risks, taking into account demographic factors, disease severity, and vaccination status.
A Rutgers University study found that COVID-19 vaccination rates were exceptionally high among LGBTQ+ adults in New Jersey and New York, but HPV vaccination had the lowest uptake rates. The study highlights age as a key predictor of vaccination uptake for most vaccines studied.
A study found that around one-third of respondents expressed mistrust in COVID-19 vaccines, with individuals who lost loved ones being nearly four times more likely to trust the science. Higher trust levels were associated with male respondents, university degrees, and above-median incomes.
A new study aims to improve vaccination rates and create new strategies to break down barriers to vaccination in populations with limited access to healthcare. The research team will develop a multilevel intervention strategy to increase vaccine uptake among adults, adolescents, families, and communities.
A new study at an allergy clinic in a diverse community found that self-identified non-White patients were less likely to show vaccine hesitancy than the White patient group. Ethnicities included in the study showed Black, Hispanic and Asian ethnicities with lower rates of refusal compared to Whites.
Researchers found that repeated mRNA vaccines enhance mucosal antibodies in nasal secretions, blocking viral entry and providing sustained protection. The immune responses generated by mRNA vaccines may persist longer than previously thought, offering hope for sustained protection against emerging COVID-19 variants.
Researchers at Nagoya University developed an innovative synthesis technology to produce high-purity, fully chemically synthesized mRNA. This breakthrough cuts down the production time and can be used to address concerns about purity and speed in mRNA vaccine development.
A groundbreaking initiative in Prince George's County, Maryland, has successfully combated COVID-19 vaccine disparities by leveraging community health workers to promote health literacy and vaccine equity. The Health Literacy Enhancement and Advancement Program (Health LEAP) reached over 14,800 residents, particularly Black and Hispani...
A new study found that COVID-19 infection increased the risk of heart attack and stroke for up to three years after infection. The risk was higher among people with A, B or AB blood types compared to type O, according to researchers analyzing data in the UK Biobank.
The authors emphasize the importance of increasing vaccination rates to combat decreasing rates globally. They also highlight emerging challenges such as a highly virulent strain of influenza and measles outbreaks, particularly in areas with low vaccination rates.
Researchers at La Jolla Institute for Immunology have developed six lines of humanized mice to study human cases of COVID-19, shedding light on SARS-CoV-2's movement through the body and varying symptoms. The models help understand how different genetic backgrounds influence disease progression.
A nationwide Swedish study found that full vaccination significantly reduced the risk of severe cardiovascular outcomes linked to COVID-19, such as heart attack and stroke. However, temporary increases in cardiovascular risk were observed after individual doses, particularly among elderly and males.
A multinational study found that people with unmedicated mental illness are less likely to be vaccinated against COVID-19, with a 9% lower vaccination rate compared to the general population. Individuals with substance use disorder were also 16% less likely to receive the vaccine.
A new poll from Michigan Medicine shows that nearly half of people age 50 and older plan to get the updated COVID-19 vaccine. However, some older adults with high risk of severe illness appear unlikely to seek the vaccine, highlighting the need for increased encouragement from clinicians and other sources.
Researchers at Boston University discovered a new method to harness self-amplifying RNA to create more effective vaccines. The modified saRNA vaccine protected mice from severe COVID-19 disease with a lower dose than current mRNA vaccines. Longer duration of protein expression and reduced inflammation were also observed.
The Advisory Committee on Immunization Practices (ACIP) has been instrumental in responding to the COVID-19 pandemic by providing transparent decision-making and prioritizing equitable access to vaccines. The committee's virtual meetings enabled timely discussions and evidence review, allowing for rapid approval of COVID-19 vaccines. H...
A new study published in Microorganisms highlights the importance of small molecule drugs that target the unchanging parts of the SARS-CoV-2 virus. The research suggests that these stable targets could provide a consistent and reliable treatment option for COVID-19, even as vaccines are updated to address changing viral strains.
Researchers developed artificial lymphoid organ-chips to recreate human immune system's response to booster vaccines. The technology could potentially be used to evaluate the likely effectiveness of new protein and mRNA-based booster vaccines for COVID-19 and other infectious diseases.
Researchers found stress, BMI, exercise, and hormonal birth control use contribute to varying experiences of post-vaccine symptoms. Women reported higher levels of stress and less regular exercise than men, while those on hormonal birth control experienced more side effects.
Researchers at UT Austin have developed a broadly neutralizing plasma antibody called SC27 that can neutralize all known COVID-19 variants. This discovery was made possible by the technology of Ig-Seq, which provides a closer look at the antibody response to infection and vaccination.
A new study from Tulane University found that state-level COVID-19 vaccination mandates increased vaccine rates among health care workers by 3-4%, with improvements seen in states that required vaccinations without opt-outs. The policy was particularly effective among health care workers between the ages of 25-49 years.
Scientists have discovered that immune cells migrate to the nasal conchae after vaccination or infection, secreting antibodies locally into the nasal cavity. This finding could lead to more effective nasal vaccinations and new treatments for autoimmune diseases.
Researchers in China used a scenario experiment to test messaging strategies on COVID-19 vaccine uptake. The study found that emphasizing personal risk rather than personal gain or community benefits was most effective in persuading people to get vaccinated.
Patients with post-COVID-19 mRNA vaccination myocarditis show lower cardiovascular complications at 18 months compared to those with conventional myocarditis. However, affected patients may require medical management for several months after hospital discharge.
A next-generation COVID-19 vaccine has been developed using a live attenuated intranasal approach, inducing strong memory responses and long-term protection. The vaccine provides cross-protection against all variants of concern and is highly effective against major SARS-CoV-2 proteins.
A cohort study found elevated depression and anxiety levels in unvaccinated people with COVID-19 diagnosis compared to before or without the virus. Vaccination was associated with lower incidence of mental illnesses after hospitalization for COVID-19.
A new study of 18 million people reveals a higher incidence of mental illnesses for up to a year following severe COVID-19, particularly in unvaccinated individuals. Vaccination appeared to mitigate the negative effects of COVID-19 on mental health.
A recent study found that US state COVID-19 vaccine mandates for healthcare workers led to increased vaccine uptake, particularly among younger workers and those in states without a test-out option. The findings suggest that vaccine mandates can further promote vaccination in already highly vaccinated healthcare populations.
A new study published in Neurology found that COVID-19 vaccination does not increase the risk of relapse in people with multiple sclerosis. However, participants with high MS activity and those who received booster doses did show a small increased risk, especially if they were not taking disease-modifying treatments.
A new study published in PLOS Computational Biology found that prioritizing older individuals for booster vaccination consistently leads to the best public health outcomes, regardless of economic level or age category. This strategy is more effective than vaccinating younger individuals with the most contacts.
Researchers at Stanford University developed a nanoparticle platform to make vaccines more effective against various pathogens. The platform allows for the elicitation of different immune responses, enabling the identification of the most effective type of protection.
A recent study found that behavioral nudges in social media ads had limited ability to encourage COVID-19 vaccination across countries. Nudge ads with messages appealing to norms and family/ community protection performed better than placebo ads, but only in certain contexts.
Researchers at the University of Houston have developed two nasal sprays, NanoSTING and NanoSTING-SN, to prevent respiratory virus transmission. NanoSTING is an immune activator that can protect against multiple viruses, while NanoSTING-SN is a pan-coronavirus vaccine that can prevent transmission to unvaccinated individuals.
A Spanish research study has described the composition of the immune system in blood samples from patients with multiple myeloma and found that altered immune cells influence vaccine efficacy. The study reveals a more severe immune suppression in patients with multiple myeloma compared to those with other tumors.
A comprehensive meta-analysis found that interventions increasing access to vaccines and providing transportation assistance tripled vaccination odds, particularly in low-income countries. Financial incentives also showed a moderate effect, but were less impactful.
A new study analyzing health records from 46 million adults in England found that COVID-19 vaccination significantly reduces the incidence of heart attacks and strokes. The incidence was up to 10% lower after the first dose and up to 27% lower after two doses, especially with the AstraZeneca vaccine.
A 50-state survey of US adults reveals decreased trust in physicians and hospitals during the COVID-19 pandemic. Lower levels of trust were associated with a lesser likelihood of pursuing vaccination, highlighting the importance of restoring public trust in healthcare.
Researchers at WashU Medicine developed a nasal COVID-19 vaccine that halted transmission in hamsters, showing promise for controlling respiratory infections. The vaccine targeted the virus's entry points in the nose and mouth, reducing viral replication and preventing spread.
A new study has found that 90-95% of participants produced strong T-cell responses after exposure to adenoviral vaccines in a lab setting. This unexpected finding may have implications for the effectiveness and safety of future COVID-19 vaccines, as well as other infectious diseases.
A large Nordic registry-based study found no association between covid-19 infection or vaccination during the first trimester and major birth defects. The study included over 343,000 infants and adjusted for various factors, providing greater confidence in its conclusions.
The risk of developing long COVID has decreased significantly over time, primarily attributed to vaccination against COVID-19. Despite this decline, the researchers found that vaccinated individuals still face a substantial risk of long COVID, with an estimated 3.5% rate in some groups.
A new approach in vaccine research, adaptive platform trials (APTs), offers a flexible adjustment of study design during ongoing clinical trials. This allows for quick adaptation to new developments and enables the recruitment of large numbers of participants across different countries.
A follow-up study found that COVID-19 infection accelerated the progression from pre-symptomatic to clinical type 1 diabetes in youth, with no observed effect in adults. Further research is needed to determine whether vaccination and monitoring for COVID-19 symptoms can help prevent or delay this progression.
Researchers discovered a correlation between higher COVID-19 vaccination rates and lower symptomatic child asthma prevalence. The study suggests that COVID-19 vaccination may provide protection against other human coronaviruses through cross-reactive antibody responses.
Researchers analyzed genomic data and human travel patterns to understand the spread and evolution of Streptococcus pneumoniae. The study found that a pneumococcal vaccine reduced antibiotic resistance but allowed non-targeted strains to gain a competitive advantage, suggesting short-lived protection.
A study published by Nemours Children's Health and Endeavor Health found that states with high COVID-19 vaccination rates saw a significant decrease in pediatric asthma symptoms, with the largest decline seen in the highest quarter of vaccination rates.
A study published in Clinical Infectious Diseases found that regular booster doses of bivalent vaccines can maintain a person's ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5. This is especially important for immunocompromised groups, such as solid organ transplant recipients.
The NIH is sponsoring a Phase 1 trial of an experimental nasal COVID-19 vaccine that may offer enhanced protection against emerging variants. The trial will enroll 60 adult participants and assess the safety and immune response of the vaccine candidate, MPV/S-2P.
A recent study investigated COVID-19 vaccine exposure in the first trimester and its potential impact on major structural birth defects. The results indicate that mRNA COVID-19 vaccine exposure during this period is not associated with an increased risk for selected birth defects among live births.
A recent study found that vaccination can reduce cognitive symptoms, including memory loss, after SARS-CoV-2 infection. Researchers identified IL-1β as a potential mechanism driving cognitive impairment and showed that prior vaccination reduced inflammation and lowered levels of this cytokine protein.
Researchers from the University of Pennsylvania found that sending well-designed reminder messages increased COVID-19 booster uptake by 21% on average, outperforming free round-trip Lyft rides. The most effective messages were those encouraging recipients to make a vaccination plan and highlighting high local transmission rates.
The Pfizer-BioNTech vaccine demonstrated strong protection against a range of COVID-19 outcomes, including hospital admission. Annual updates to the vaccine are recommended due to waning immunity from older versions.